John R. Ingrassia

John Ingrassia is a senior counsel in the Corporate Department of Proskauer Rose. He advises clients on a wide range of antitrust matters in various industries, including chemicals, pharmaceutical, medical devices, telecommunications, financial services, health care, and others. His practice includes a focus on the analysis and resolution of antitrust issues related to mergers, acquisitions, and joint ventures, and the analysis of Hart-Scott-Rodino pre-merger notification requirements. John has extensive experience with the legal, practical, and technical requirements of merger clearance and the Hart-Scott-Rodino Act, and is regularly invited to participate in Federal Trade Commission and bar association discussions regarding Hart-Scott-Rodino practice issues.

In addition, John also advises clients regarding international antitrust issues arising in proposed acquisitions and joint ventures, including reportability under the EC Merger Regulation and numerous other foreign merger control regimes, and liaising with local counsel to coordinate foreign pre-merger notifications and ensure the efficacy and consistency of the competition law theories advanced. John also advises clients on issues related to CFIUS national security review, and on CIFIUS submissions.

Client Representations:

*Annie’s, Inc., a natural and organic food company with a widely recognized brand, before the FTC in its $820 million sale to General Mills, Inc. to join General Mills’ U.S. natural and organic products portfolio

*
Sherman Health Systems in its merger with Advocate Health Care, making Sherman part of the largest hospital network in the State of Illinois

*
Cervecería Costa Rica S.A.’s acquisition of North American Breweries Holdings, LLC

*
Ares Management LLC in their acquisition of Smart & Final Holdings Corp.

*
Grey Mountain Partners in the sale of Robbins Holdings, Inc. to HEXPOL AB

*
A private equity fund and its affiliate in its million acquisition of Global Defense Technology & Systems, Inc. (n/k/a Sotera Defense Solutions, Inc.), a provider of mission-critical solutions for national security agencies and programs of the U.S. government

*
HCM Custom Holdings, Inc., a provider of complex electronics manufacturing solutions to the aerospace, defense and space industries, in its $135 million acquisition by Safran Group

*
Grifols, S.A., a global health care company in one of the most intense antitrust investigations in recent FTC history, resulting in the approval of its $4 billion acquisition of Talecris Biotherapeutics Holdings Corp., creating the world's third-largest plasma-products manufacturer.

*
Henry Schein, before the FTC, in the merger of Henry Schein's U.S. Animal Health businesses and Butler Animal Health Supply

*
Disc-O-Tech Medical Technologies Ltd., before the FTC, in its sales of medical device assets to Kyphon, Inc.

*Laird Group PLC in:

*its $90 million acquisition of Cushcraft, Inc., a company engaged in the design of cellular, PCS, GPS, and mobile radio antennas and related products

*the sale of its subsidiaries within its Laird Security Systems/Amesbury division to Lupus Capital PLC

*its acquisition of Microwave Materials Group, the holding company of Emerson & Cuming Microwave Products

*Andrx Corporation, before the FTC, in its $1.9 billion acquisition by Watson Pharmaceuticals Inc. to create the third largest generic pharmaceutical company in the United States

*
Trusted Computer Solutions, a privately-held company that delivers a comprehensive portfolio of cross-domain operating system and network security solutions, in its sale to Raytheon Company (NASDAQ: RTN)

*
West Virginia United Health Systems in its acquisition and affiliation with Camden-Clark Memorial Hospital and St. Joseph’s Hospital in Parkersburg, West Virginia.

*
Votorantim Metais Ltda. regarding antitrust advice before the FTC, with respect to the $295 million acquisition by its affiliates of US Zinc from Aleris International, Inc.

*
Suburban Propane Partners, L.P. in its $1.8 billion acquisition of the retail propane assets and operations of Inergy, L.P. and certain of its affiliates

*
New York Downtown Hospital in its strategic alliance with New York Presbyterian Hospital

*
Bed Bath & Beyond Inc. in securing antitrust clearance for its acquisition of Cost Plus, Inc.

Selected Publications and Speaking Engagements

*“Restraints of Trade and Dominance in the United States: Overview,” Practical Law’s Multi-Jurisdictional Guide 2014/15 Competition and Cartel Leniency, co-authored with Alicia Batts and Rhett Krulla (July 2014)

*
ABA International Antitrust Committee Newsletter, U.S. Antitrust Enforcement: New Chiefs, Same Global Focus (Summer 2013)

*
ABA Program, "Associates" Under the New HSR Rules (March 2013)

*
"Re-Animator" or "Dead Man Walking"? FTC Says No to Zombie Deal Reviews – Formalizes Withdrawal and Refiling Procedure (July, 2013)

*
Family Dining Meets Value Investing – Proxy Battle Spills Over into Antitrust Arena and Lands Investor $850,000 Penalty, October 2012

*
“USA Year in Review,” 2012 Antitrust Year in Review, co-authored with Alicia Batts (January 2012)

*
“As M&A Challenges Abound – More Headaches for Dealmakers,” Bloomberg Law Reports – Antitrust & Trade (August 22, 2011)

*
"DOJ Merger Policy Shines New Light on Conduct Remedies," Association of Corporate Counsel, Lexology, co-authored with Colin Kass (June 2011)

*"Demanding Antitrust Side-Letter Disclosure," LAW360, co-authored with Colin Kass (April 2011)